{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:38:32Z","timestamp":1789609112304,"version":"build-2803163510"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11926-025-01182-z","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T04:29:31Z","timestamp":1738211371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["An Update on Multi-System Inflammatory Syndrome in Children"],"prefix":"10.1007","volume":"27","author":[{"given":"Anurag Ratan","family":"Goel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Yalcindag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"key":"1182_CR1","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMoa2021756","volume":"383","author":"EM Dufort","year":"2020","unstructured":"Dufort EM, Koumans EH, Chow EJ, et al. Multisystem inflammatory syndrome in children in New York State. N Engl J Med. 2020;383:347\u201358.","journal-title":"N Engl J Med"},{"key":"1182_CR2","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1056\/NEJMoa2021680","volume":"383","author":"LR Feldstein","year":"2020","unstructured":"Feldstein LR, Rose EB, Horwitz SM, et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383:334\u201346.","journal-title":"N Engl J Med"},{"key":"1182_CR3","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.15585\/mmwr.mm6932e2","volume":"69","author":"S Godfred-Cato","year":"2020","unstructured":"Godfred-Cato S, Bryant B, Leung J, et al. COVID-19-associated multisystem inflammatory syndrome in children - United States, march-July 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1074\u201380.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1182_CR4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1002\/art.42062","volume":"74","author":"LA Henderson","year":"2022","unstructured":"Henderson LA, Canna SW, Friedman KG, et al. American college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS\u2013CoV-2 and hyperinflammation in pediatric COVID-19: Version 3. Arthritis Rheumatol. 2022;74:e1\u201320.","journal-title":"Arthritis Rheumatol"},{"key":"1182_CR5","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/S0140-6736(20)31103-X","volume":"395","author":"L Verdoni","year":"2020","unstructured":"Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, Bonanomi E, D\u2019Antiga L. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395:1771\u20138.","journal-title":"Lancet"},{"key":"1182_CR6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1001\/jama.2020.10369","volume":"324","author":"E Whittaker","year":"2020","unstructured":"Whittaker E, Bamford A, Kenny J, et al. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. JAMA. 2020;324:259\u201369.","journal-title":"JAMA"},{"key":"1182_CR7","doi-asserted-by":"publisher","first-page":"5942","DOI":"10.1172\/JCI141113","volume":"130","author":"PY Lee","year":"2020","unstructured":"Lee PY, Day-Lewis M, Henderson LA, et al. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. J Clin Invest. 2020;130:5942\u201350.","journal-title":"J Clin Invest"},{"key":"1182_CR8","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0140-6736(20)31094-1","volume":"395","author":"S Riphagen","year":"2020","unstructured":"Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395:1607\u20138.","journal-title":"Lancet"},{"key":"1182_CR9","doi-asserted-by":"publisher","first-page":"m2094","DOI":"10.1136\/bmj.m2094","volume":"369","author":"J Toubiana","year":"2020","unstructured":"Toubiana J, Poirault C, Corsia A, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. 2020;369:m2094.","journal-title":"BMJ"},{"key":"1182_CR10","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1001\/jamapediatrics.2021.0630","volume":"175","author":"ED Belay","year":"2021","unstructured":"Belay ED, Abrams J, Oster ME, et al. Trends in geographic and temporal distribution of US children with multisystem inflammatory syndrome during the COVID-19 pandemic. JAMA Pediatr. 2021;175:837\u201345.","journal-title":"JAMA Pediatr"},{"key":"1182_CR11","doi-asserted-by":"crossref","unstructured":"Yousaf AR, Lindsey KN, Wu MJ, Shah AB, Free RJ, Simeone RM, Zambrano LD, Campbell AP, MIS-C Surveillance Authorship Group. Notes from the field: surveillance for multisystem inflammatory syndrome in children - United States, 2023. MMWR Morb Mortal Wkly Rep 2024;73:225\u2013228","DOI":"10.15585\/mmwr.mm7310a2"},{"key":"1182_CR12","doi-asserted-by":"publisher","first-page":"873","DOI":"10.21037\/tp-20-151","volume":"9","author":"W Li","year":"2020","unstructured":"Li W, Tang Y, Shi Y, Chen Y, Liu E. Why multisystem inflammatory syndrome in children has been less commonly described in Asia? Transl Pediatr. 2020;9:873\u20135.","journal-title":"Transl Pediatr"},{"key":"1182_CR13","doi-asserted-by":"publisher","first-page":"e001034","DOI":"10.1136\/bmjpo-2021-001034","volume":"5","author":"K Iio","year":"2021","unstructured":"Iio K, Matsubara K, Miyakoshi C, Ota K, Yamaoka R, Eguchi J, Matsumura O, Okutani T, Ueda I, Nishiyama M. Incidence of Kawasaki disease before and during the COVID-19 pandemic: a retrospective cohort study in Japan. BMJ Paediatr Open. 2021;5:e001034.","journal-title":"BMJ Paediatr Open"},{"key":"1182_CR14","doi-asserted-by":"publisher","first-page":"21005","DOI":"10.1038\/s41598-023-47655-y","volume":"13","author":"S Rao","year":"2023","unstructured":"Rao S, Jing N, Liu X, et al. Spectrum of severity of multisystem inflammatory syndrome in children: an EHR-based cohort study from the RECOVER program. Sci Rep. 2023;13:21005.","journal-title":"Sci Rep"},{"key":"1182_CR15","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41390-023-02633-y","volume":"95","author":"N Auger","year":"2024","unstructured":"Auger N, C\u00f4t\u00e9-Corriveau G, Kang H, Quach C, Lo E, Lee GE, Healy-Profit\u00f3s J, Brousseau \u00c9, Luu TM. Multisystem inflammatory syndrome in 1.2 million children: longitudinal cohort study of risk factors. Pediatr Res. 2024;95:325\u201333.","journal-title":"Pediatr Res"},{"key":"1182_CR16","doi-asserted-by":"publisher","first-page":"e2020039933","DOI":"10.1542\/peds.2020-039933","volume":"147","author":"K Javalkar","year":"2021","unstructured":"Javalkar K, Robson VK, Gaffney L, et al. Socioeconomic and racial and\/or ethnic disparities in multisystem inflammatory syndrome. Pediatrics. 2021;147:e2020039933.","journal-title":"Pediatrics"},{"key":"1182_CR17","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1097\/INF.0000000000003689","volume":"41","author":"LD Zambrano","year":"2022","unstructured":"Zambrano LD, Ly KN, Link-Gelles R, et al. Investigating health disparities associated with multisystem inflammatory syndrome in children after SARS-CoV-2 infection. Pediatr Infect Dis J. 2022;41:891\u20138.","journal-title":"Pediatr Infect Dis J"},{"key":"1182_CR18","doi-asserted-by":"publisher","first-page":"e190","DOI":"10.1097\/INF.0000000000003900","volume":"42","author":"LD Zambrano","year":"2023","unstructured":"Zambrano LD, Wu MJ, Martin L, et al. Risk factors for multisystem inflammatory syndrome in children: a case-control investigation. Pediatr Infect Dis J. 2023;42:e190\u20136.","journal-title":"Pediatr Infect Dis J"},{"key":"1182_CR19","doi-asserted-by":"publisher","unstructured":"Chang JC, Son MBF. When vaccine adverse event reporting generates hope, not fear. Lancet Child Adolescent Health.2022. https:\/\/doi.org\/10.1016\/S2352-4642(22)00061-X","DOI":"10.1016\/S2352-4642(22)00061-X"},{"key":"1182_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12969-023-00848-1","volume":"21","author":"M Hamad Saied","year":"2023","unstructured":"Hamad Saied M, van der Griend L, van Straalen JW, Wulffraat NM, Vastert S, Jansen MHA. The protective effect of COVID-19 vaccines on developing multisystem inflammatory syndrome in children (MIS-C): a systematic literature review and meta-analysis. Pediatr Rheumatol Online J. 2023;21:80.","journal-title":"Pediatr Rheumatol Online J"},{"key":"1182_CR21","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.jmii.2023.08.002","volume":"56","author":"T-H Liu","year":"2023","unstructured":"Liu T-H, Huang P-Y, Wu J-Y, Chung K-M, Lai C-C, Tang H-J. Effectiveness of COVID-19 vaccination against multisystem inflammatory syndrome in children: A systematic review and meta-analysis. J Microbiol Immunol Infect. 2023;56:1299\u2013300.","journal-title":"J Microbiol Immunol Infect"},{"key":"1182_CR22","doi-asserted-by":"publisher","unstructured":"Yousaf AR, Cortese MM, Taylor AW, et al. Reported cases of multisystem inflammatory syndrome in children aged 12\u201320 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigation. Lancet Child Adolescent Health. 2021. https:\/\/doi.org\/10.1016\/S2352-4642(22)00028-1","DOI":"10.1016\/S2352-4642(22)00028-1"},{"key":"1182_CR23","doi-asserted-by":"publisher","unstructured":"Zambrano LD. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12\u201318 years \u2014 United States, July\u2013December 2021. MMWR Morb Mortal Wkly Rep. 2022. https:\/\/doi.org\/10.15585\/mmwr.mm7102e1","DOI":"10.15585\/mmwr.mm7102e1"},{"key":"1182_CR24","doi-asserted-by":"publisher","first-page":"e13900","DOI":"10.1111\/pai.13900","volume":"34","author":"W Feleszko","year":"2023","unstructured":"Feleszko W, Okarska-Napiera\u0142a M, Buddingh EP, et al. Pathogenesis, immunology, and immune-targeted management of the multisystem inflammatory syndrome in children (MIS-C) or pediatric inflammatory multisystem syndrome (PIMS): EAACI Position Paper. Pediatr Allergy Immunol. 2023;34:e13900.","journal-title":"Pediatr Allergy Immunol"},{"key":"1182_CR25","doi-asserted-by":"publisher","first-page":"7222","DOI":"10.1038\/s41467-021-27544-6","volume":"12","author":"C Diorio","year":"2021","unstructured":"Diorio C, Shraim R, Vella LA, et al. Proteomic profiling of MIS-C patients indicates heterogeneity relating to interferon gamma dysregulation and vascular endothelial dysfunction. Nat Commun. 2021;12:7222.","journal-title":"Nat Commun"},{"key":"1182_CR26","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1038\/s41390-022-02029-4","volume":"92","author":"SL Gurlevik","year":"2022","unstructured":"Gurlevik SL, Ozsurekci Y, Sa\u011f E, et al. The difference of the inflammatory milieu in MIS-C and severe COVID-19. Pediatr Res. 2022;92:1805\u201314.","journal-title":"Pediatr Res"},{"key":"1182_CR27","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11882-023-01083-0","volume":"23","author":"L Cannon","year":"2023","unstructured":"Cannon L, Campbell MJ, Wu EY. Multisystemic Inflammatory Syndrome in Children and Kawasaki Disease: Parallels in Pathogenesis and Treatment. Curr Allergy Asthma Rep. 2023;23:341\u201350.","journal-title":"Curr Allergy Asthma Rep"},{"key":"1182_CR28","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1161\/ATVBAHA.121.316210","volume":"41","author":"W-T Wang","year":"2021","unstructured":"Wang W-T, He M, Shimizu C, Croker BA, Hoffman HM, Tremoulet AH, Burns JC, Shyy JY-J. Inflammasome Activation in Children With Kawasaki Disease and Multisystem Inflammatory Syndrome. Arterioscler Thromb Vasc Biol. 2021;41:2509\u201311.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1182_CR29","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1097\/INF.0000000000004267","volume":"43","author":"S Yeoh","year":"2024","unstructured":"Yeoh S, Estrada-Rivadeneyra D, Jackson H, et al. Plasma Protein Biomarkers Distinguish Multisystem Inflammatory Syndrome in Children From Other Pediatric Infectious and Inflammatory Diseases. Pediatr Infect Dis J. 2024;43:444\u201353.","journal-title":"Pediatr Infect Dis J"},{"key":"1182_CR30","doi-asserted-by":"publisher","first-page":"e329","DOI":"10.1016\/S2665-9913(22)00064-9","volume":"4","author":"J Pfeifer","year":"2022","unstructured":"Pfeifer J, Thurner B, Kessel C, et al. Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study. Lancet Rheumatol. 2022;4:e329\u201337.","journal-title":"Lancet Rheumatol"},{"key":"1182_CR31","doi-asserted-by":"publisher","first-page":"104736","DOI":"10.1016\/j.ebiom.2023.104736","volume":"95","author":"SA Netea","year":"2023","unstructured":"Netea SA, Biesbroek G, van Stijn D, et al. Transient anti-cytokine autoantibodies superimpose the hyperinflammatory response in Kawasaki disease and multisystem inflammatory syndrome in children: a comparative cohort study on correlates of disease. EBioMedicine. 2023;95:104736.","journal-title":"EBioMedicine"},{"key":"1182_CR32","doi-asserted-by":"publisher","first-page":"e147076","DOI":"10.1172\/JCI147076","volume":"131","author":"YP Zhu","year":"2021","unstructured":"Zhu YP, Shamie I, Lee JC, et al. Immune response to intravenous immunoglobulin in patients with Kawasaki disease and MIS-C. J Clin Invest. 2021;131:e147076.","journal-title":"J Clin Invest"},{"key":"1182_CR33","doi-asserted-by":"publisher","first-page":"e171729","DOI":"10.1172\/JCI171729","volume":"133","author":"TE Andargie","year":"2023","unstructured":"Andargie TE, Roznik K, Redekar N, et al. Cell-free DNA reveals distinct pathology of multisystem inflammatory syndrome in children. J Clin Invest. 2023;133:e171729.","journal-title":"J Clin Invest"},{"key":"1182_CR34","doi-asserted-by":"publisher","first-page":"25254","DOI":"10.1073\/pnas.2010722117","volume":"117","author":"MH Cheng","year":"2020","unstructured":"Cheng MH, Zhang S, Porritt RA, Noval Rivas M, Paschold L, Willscher E, Binder M, Arditi M, Bahar I. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation. Proc Natl Acad Sci U S A. 2020;117:25254\u201362.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1182_CR35","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1126\/sciimmunol.abh1516","volume":"6","author":"M Moreews","year":"2021","unstructured":"Moreews M, Le Gouge K, Khaldi-Plassart S, et al. Polyclonal expansion of TCR Vbeta 2.13+ CD4+ and CD8+ T cells is a hallmark of Multisystem Inflammatory Syndrome in Children. Sci Immunol. 2021;6:1516.","journal-title":"Sci Immunol"},{"key":"1182_CR36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jaci.2020.10.008","volume":"147","author":"M Noval Rivas","year":"2021","unstructured":"Noval Rivas M, Porritt RA, Cheng MH, Bahar I, Arditi M. COVID-19-associated multisystem inflammatory syndrome in children (MIS-C): A novel disease that mimics toxic shock syndrome-the superantigen hypothesis. J Allergy Clin Immunol. 2021;147:57\u20139.","journal-title":"J Allergy Clin Immunol"},{"key":"1182_CR37","doi-asserted-by":"publisher","first-page":"e146614","DOI":"10.1172\/JCI146614","volume":"131","author":"RA Porritt","year":"2021","unstructured":"Porritt RA, Paschold L, Rivas MN, et al. HLA class I-associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children. J Clin Invest. 2021;131:e146614.","journal-title":"J Clin Invest"},{"key":"1182_CR38","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/s41591-022-01724-3","volume":"28","author":"K Sacco","year":"2022","unstructured":"Sacco K, Castagnoli R, Vakkilainen S, et al. Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19. Nat Med. 2022;28:1050\u201362.","journal-title":"Nat Med"},{"key":"1182_CR39","doi-asserted-by":"publisher","first-page":"4854","DOI":"10.1038\/s41467-021-24981-1","volume":"12","author":"ND Beckmann","year":"2021","unstructured":"Beckmann ND, Comella PH, Cheng E, et al. Downregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children. Nat Commun. 2021;12:4854.","journal-title":"Nat Commun"},{"key":"1182_CR40","doi-asserted-by":"publisher","first-page":"eabf7570","DOI":"10.1126\/sciimmunol.abf7570","volume":"6","author":"LA Vella","year":"2021","unstructured":"Vella LA, Giles JR, Baxter AE, et al. Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19. Sci Immunol. 2021;6:eabf7570.","journal-title":"Sci Immunol"},{"key":"1182_CR41","doi-asserted-by":"publisher","first-page":"e149633","DOI":"10.1172\/JCI149633","volume":"131","author":"LM Yonker","year":"2021","unstructured":"Yonker LM, Gilboa T, Ogata AF, et al. Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier. J Clin Invest. 2021;131:e149633.","journal-title":"J Clin Invest"},{"key":"1182_CR42","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1038\/s41591-020-1054-6","volume":"26","author":"MJ Carter","year":"2020","unstructured":"Carter MJ, Fish M, Jennings A, et al. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection. Nat Med. 2020;26:1701\u20137.","journal-title":"Nat Med"},{"key":"1182_CR43","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1007\/s00431-023-04906-4","volume":"182","author":"D Mascarenhas","year":"2023","unstructured":"Mascarenhas D, Goyal M, Haribalakrishna A, Nanavati R, Ish P, Kunal S. Multisystem inflammatory syndrome in neonates (MIS-N): a systematic review. Eur J Pediatr. 2023;182:2283\u201398.","journal-title":"Eur J Pediatr"},{"key":"1182_CR44","doi-asserted-by":"publisher","first-page":"12836","DOI":"10.3390\/ijms232112836","volume":"23","author":"S Perrone","year":"2022","unstructured":"Perrone S, Cannav\u00f2 L, Manti S, Rullo I, Buonocore G, Esposito SMR, Gitto E. Pediatric Multisystem Syndrome Associated with SARS-CoV-2 (MIS-C): The Interplay of Oxidative Stress and Inflammation. Int J Mol Sci. 2022;23:12836.","journal-title":"Int J Mol Sci"},{"key":"1182_CR45","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S2352-4642(20)30257-1","volume":"4","author":"M Dolhnikoff","year":"2020","unstructured":"Dolhnikoff M, Ferreira Ferranti J, de Almeida Monteiro RA, et al. SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome. Lancet Child Adolesc Health. 2020;4:790\u20134.","journal-title":"Lancet Child Adolesc Health"},{"key":"1182_CR46","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.amjcard.2021.12.031","volume":"168","author":"DL Li","year":"2022","unstructured":"Li DL, Davogustto G, Soslow JH, et al. Characteristics of COVID-19 Myocarditis With and Without Multisystem Inflammatory Syndrome. Am J Cardiol. 2022;168:135\u201341.","journal-title":"Am J Cardiol"},{"key":"1182_CR47","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00431-020-03766-6","volume":"180","author":"F Sperotto","year":"2021","unstructured":"Sperotto F, Friedman KG, Son MBF, VanderPluym CJ, Newburger JW, Dionne A. Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach. Eur J Pediatr. 2021;180:307\u201322.","journal-title":"Eur J Pediatr"},{"key":"1182_CR48","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.jaci.2021.06.024","volume":"148","author":"J Chou","year":"2021","unstructured":"Chou J, Platt CD, Habiballah S, et al. Mechanisms underlying genetic susceptibility to multisystem inflammatory syndrome in children (MIS-C). J Allergy Clin Immunol. 2021;148:732-738.e1.","journal-title":"J Allergy Clin Immunol"},{"key":"1182_CR49","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.jaci.2020.07.033","volume":"146","author":"PY Lee","year":"2020","unstructured":"Lee PY, Platt CD, Weeks S, et al. Immune dysregulation and multisystem inflammatory syndrome in children (MIS-C) in individuals with haploinsufficiency of SOCS1. J Allergy Clin Immunol. 2020;146:1194-1200.e1.","journal-title":"J Allergy Clin Immunol"},{"key":"1182_CR50","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/jpids\/piad035","volume":"12","author":"HR Jackson","year":"2023","unstructured":"Jackson HR, Miglietta L, Habgood-Coote D, et al. Diagnosis of Multisystem Inflammatory Syndrome in Children by a Whole-Blood Transcriptional Signature. J Pediatric Infect Dis Soc. 2023;12:322\u201331.","journal-title":"J Pediatric Infect Dis Soc"},{"key":"1182_CR51","doi-asserted-by":"publisher","first-page":"101515","DOI":"10.1016\/j.eclinm.2022.101515","volume":"50","author":"V Davalos","year":"2022","unstructured":"Davalos V, Garc\u00eda-Prieto CA, Ferrer G, et al. Epigenetic profiling linked to multisystem inflammatory syndrome in children (MIS-C): A multicenter, retrospective study. EClinicalMedicine. 2022;50:101515.","journal-title":"EClinicalMedicine"},{"key":"1182_CR52","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1161\/CIRCULATIONAHA.120.049836","volume":"143","author":"T Alsaied","year":"2021","unstructured":"Alsaied T, Tremoulet AH, Burns JC, Saidi A, Dionne A, Lang SM, Newburger JW, de Ferranti S, Friedman KG. Review of cardiac involvement in multisystem inflammatory syndrome in children. Circulation. 2021;143:78\u201388.","journal-title":"Circulation"},{"key":"1182_CR53","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1161\/CIRCULATIONAHA.120.048360","volume":"142","author":"Z Belhadjer","year":"2020","unstructured":"Belhadjer Z, M\u00e9ot M, Bajolle F, et al. Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic. Circulation. 2020;142:429\u201336.","journal-title":"Circulation"},{"key":"1182_CR54","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jpeds.2020.06.044","volume":"224","author":"CA Capone","year":"2020","unstructured":"Capone CA, Subramony A, Sweberg T, et al. Characteristics, cardiac involvement, and outcomes of multisystem inflammatory syndrome of childhood associated with severe acute respiratory syndrome coronavirus 2 infection. J Pediatr. 2020;224:141\u20135.","journal-title":"J Pediatr"},{"key":"1182_CR55","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1001\/jama.2021.2091","volume":"325","author":"LR Feldstein","year":"2021","unstructured":"Feldstein LR, Tenforde MW, Friedman KG, et al. Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. JAMA. 2021;325:1074\u201387.","journal-title":"JAMA"},{"key":"1182_CR56","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jpeds.2020.12.033","volume":"234","author":"W Regan","year":"2021","unstructured":"Regan W, O\u2019Byrne L, Stewart K, Miller O, Pushparajah K, Theocharis P, Wong J, Rosenthal E. Electrocardiographic changes in children with multisystem inflammation associated with COVID-19: associated with coronavirus disease 2019. J Pediatr. 2021;234:27-32.e2.","journal-title":"J Pediatr"},{"key":"1182_CR57","doi-asserted-by":"publisher","first-page":"e018007","DOI":"10.1161\/JAHA.120.018007","volume":"9","author":"BC Clark","year":"2020","unstructured":"Clark BC, Sanchez-de-Toledo J, Bautista-Rodriguez C, et al. Cardiac abnormalities seen in pediatric patients during the SARS-CoV2 Pandemic: An international experience. J Am Heart Assoc. 2020;9:e018007.","journal-title":"J Am Heart Assoc"},{"key":"1182_CR58","doi-asserted-by":"publisher","first-page":"108780","DOI":"10.1016\/j.clim.2021.108780","volume":"229","author":"S Felsenstein","year":"2021","unstructured":"Felsenstein S, Duong P, Lane S, Jones C, Pain CE, Hedrich CM. Cardiac pathology and outcomes vary between Kawasaki disease and PIMS-TS. Clin Immunol. 2021;229:108780.","journal-title":"Clin Immunol"},{"key":"1182_CR59","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/j.jacc.2020.08.056","volume":"76","author":"D Matsubara","year":"2020","unstructured":"Matsubara D, Kauffman HL, Wang Y, et al. Echocardiographic findings in pediatric multisystem inflammatory syndrome associated with COVID-19 in the United States. J Am Coll Cardiol. 2020;76:1947\u201361.","journal-title":"J Am Coll Cardiol"},{"key":"1182_CR60","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jpeds.2021.09.026","volume":"240","author":"J Pick","year":"2022","unstructured":"Pick J, Rao MY, Dern K, Wang S, Szmuszkovicz J, Wagner-Lees S, Badran S, Wong PC, Votava-Smith JK. Coronary artery changes in patients with multisystem inflammatory syndrome in children: Los Angeles experience. J Pediatr. 2022;240:292\u20136.","journal-title":"J Pediatr"},{"key":"1182_CR61","doi-asserted-by":"publisher","first-page":"e2432","DOI":"10.1002\/rmv.2432","volume":"33","author":"MAF Arantes Junior","year":"2023","unstructured":"Arantes Junior MAF, Conegundes AF, Branco Miranda BC, Radicchi Campos ASR, Fran\u00e7a Vieira AL, Faleiro MD, Campos MA, Kroon EG, Bentes AA. Cardiac manifestations in children with the multisystem inflammatory syndrome (MIS-C) associated with SARS-CoV-2 infection: Systematic review and meta-analysis. Rev Med Virol. 2023;33:e2432.","journal-title":"Rev Med Virol"},{"key":"1182_CR62","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1017\/S104795112300015X","volume":"33","author":"CA Carmona","year":"2023","unstructured":"Carmona CA, Kuziez M, Freitas CF, Cyrus JW, Bain J, Karam O. Cardiac manifestations of multisystem inflammatory syndrome of children after SARS-CoV-2 infection: a systematic review and meta-analysis. Cardiol Young. 2023;33:2319\u201327.","journal-title":"Cardiol Young"},{"key":"1182_CR63","unstructured":"Centers for Disease Control and Prevention. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19).2024. https:\/\/archive.cdc.gov\/emergency_cdc_gov\/han\/2020\/han00432.asp. Accessed 18 May 2024"},{"key":"1182_CR64","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S2352-4642(20)30304-7","volume":"5","author":"R Harwood","year":"2021","unstructured":"Harwood R, Allin B, Jones CE, et al. A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process. Lancet Child Adolescent Health. 2021;5:133\u201341.","journal-title":"Lancet Child Adolescent Health"},{"key":"1182_CR65","unstructured":"World Health Organization. Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19. 2020. https:\/\/www.who.int\/news-room\/commentaries\/detail\/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19. Accessed 19 May 2024"},{"key":"1182_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7104a1","volume":"71","author":"M Melgar","year":"2022","unstructured":"Melgar M, Lee EH, Miller AD, et al. Council of state and territorial epidemiologists\/CDC surveillance case definition for multisystem inflammatory syndrome in children associated with SARS-CoV-2 Infection - United States. MMWR Recomm Rep. 2022;71:1\u201314.","journal-title":"MMWR Recomm Rep"},{"key":"1182_CR67","unstructured":"American Academy of Pediatrics. Multisystem Inflammatory Syndrome in Children (MIS-C) Interim Guidance. 2023. https:\/\/www.aap.org\/en\/pages\/2019-novel-coronavirus-covid-19-infections\/clinical-guidance\/multisystem-inflammatory-syndrome-in-children-mis-c-interim-guidance\/. Accessed 19 May 2024"},{"key":"1182_CR68","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12969-022-00771-x","volume":"20","author":"T Tong","year":"2022","unstructured":"Tong T, Yao X, Lin Z, et al. Similarities and differences between MIS-C and KD: a systematic review and meta-analysis. Pediatr Rheumatol Online J. 2022;20:112.","journal-title":"Pediatr Rheumatol Online J"},{"key":"1182_CR69","doi-asserted-by":"publisher","first-page":"4358","DOI":"10.1002\/jmv.26951","volume":"93","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Yin L, Patel J, Tang L, Huang Y. The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: A meta-analysis. J Med Virol. 2021;93:4358\u201369.","journal-title":"J Med Virol"},{"key":"1182_CR70","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.1002\/ppul.25687","volume":"56","author":"C Zhou","year":"2021","unstructured":"Zhou C, Zhao Y, Wang X, Huang Y, Tang X, Tang L. Laboratory parameters between multisystem inflammatory syndrome in children and Kawasaki disease. Pediatr Pulmonol. 2021;56:3688\u201398.","journal-title":"Pediatr Pulmonol"},{"key":"1182_CR71","doi-asserted-by":"publisher","unstructured":"Godfred-Cato S, Abrams JY, Balachandran N, et al. Distinguishing Multisystem Inflammatory Syndrome in Children From COVID-19, Kawasaki Disease and Toxic Shock Syndrome. Pediatr Infect Dis J. 2022. https:\/\/doi.org\/10.1097\/INF.0000000000003449","DOI":"10.1097\/INF.0000000000003449"},{"key":"1182_CR72","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-023-03338-z","author":"M Walton","year":"2023","unstructured":"Walton M, Raghuveer G, Harahsheh A, et al. Cardiac biomarkers aid in differentiation of kawasaki disease from multisystem inflammatory syndrome in children associated with COVID-19. Pediatr Cardiol. 2023. https:\/\/doi.org\/10.1007\/s00246-023-03338-z.","journal-title":"Pediatr Cardiol"},{"key":"1182_CR73","doi-asserted-by":"publisher","first-page":"e2023063259","DOI":"10.1542\/peds.2023-063259","volume":"153","author":"M Day-Lewis","year":"2024","unstructured":"Day-Lewis M, Berbert L, Baker A, Dionne A, Newburger JW, Son MBF. Updated case definition of MIS-C and implications for clinical care. Pediatrics. 2024;153:e2023063259.","journal-title":"Pediatrics"},{"key":"1182_CR74","doi-asserted-by":"publisher","first-page":"4889","DOI":"10.1007\/s00431-023-05142-6","volume":"182","author":"M Fabi","year":"2023","unstructured":"Fabi M, Dondi A, Andreozzi L, Frazzoni L, Biserni GB, Ghiazza F, Dajti E, Zagari RM, Lanari M. Kawasaki disease, multisystem inflammatory syndrome in children, and adenoviral infection: a scoring system to guide differential diagnosis. Eur J Pediatr. 2023;182:4889\u201395.","journal-title":"Eur J Pediatr"},{"key":"1182_CR75","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/acr2.11509","volume":"4","author":"MT Clark","year":"2022","unstructured":"Clark MT, Rankin DA, Peetluk LS, et al. A diagnostic prediction model to distinguish multisystem inflammatory syndrome in children. ACR Open Rheumatol. 2022;4:1050\u20139.","journal-title":"ACR Open Rheumatol"},{"key":"1182_CR76","doi-asserted-by":"publisher","first-page":"e717","DOI":"10.1016\/S2589-7500(22)00149-2","volume":"4","author":"JY Lam","year":"2022","unstructured":"Lam JY, Shimizu C, Tremoulet AH, et al. A machine-learning algorithm for diagnosis of multisystem inflammatory syndrome in children and Kawasaki disease in the USA: a retrospective model development and validation study. Lancet Digit Health. 2022;4:e717\u201326.","journal-title":"Lancet Digit Health"},{"key":"1182_CR77","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/jhm.13290","volume":"19","author":"LS Starnes","year":"2024","unstructured":"Starnes LS, Starnes JR, Stopczynski T, et al. Clinical prediction model: Multisystem inflammatory syndrome in children versus Kawasaki disease. J Hosp Med. 2024;19:175\u201384.","journal-title":"J Hosp Med"},{"key":"1182_CR78","doi-asserted-by":"publisher","first-page":"e280","DOI":"10.1542\/hpeds.2022-007107","volume":"13","author":"LK Fan","year":"2023","unstructured":"Fan LK, Bai S, Du C, Bass M, Jones K, Sherry W, Morris CR, Oster ME, Shane AL, Jaggi P. Distinguishing incomplete kawasaki and nonsevere multisystem inflammatory syndrome in children. Hosp Pediatr. 2023;13:e280\u20134.","journal-title":"Hosp Pediatr"},{"key":"1182_CR79","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1097\/PCC.0000000000002598","volume":"22","author":"B Jonat","year":"2021","unstructured":"Jonat B, Gorelik M, Boneparth A, et al. Multisystem inflammatory syndrome in children associated with coronavirus disease 2019 in a children\u2019s hospital in new york city: patient characteristics and an institutional protocol for evaluation, management, and follow-up. Pediatr Crit Care Med. 2021;22:e178\u201391.","journal-title":"Pediatr Crit Care Med"},{"key":"1182_CR80","doi-asserted-by":"publisher","unstructured":"Jonat B, Geneslaw AS, Capone CA, Shah S, Bartucca L, Sewell TB, Acker KP, Mitchell E, Cheung EW. Early treatment of multisystem inflammatory syndrome in children. Pediatrics. 2023;152(3):e2023061297. https:\/\/doi.org\/10.1542\/peds.2023-061297.","DOI":"10.1542\/peds.2023-061297"},{"key":"1182_CR81","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S2352-4642(20)30215-7","volume":"4","author":"P Davies","year":"2020","unstructured":"Davies P, Evans C, Kanthimathinathan HK, et al. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study. Lancet Child Adolesc Health. 2020;4:669\u201377.","journal-title":"Lancet Child Adolesc Health"},{"key":"1182_CR82","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa2102605","volume":"385","author":"MBF Son","year":"2021","unstructured":"Son MBF, Murray N, Friedman K, et al. Multisystem Inflammatory syndrome in children - initial therapy and outcomes. N Engl J Med. 2021;385:23\u201334.","journal-title":"N Engl J Med"},{"key":"1182_CR83","unstructured":"World Health Organization. Living guidance for clinical management of COVID-19. 2021. https:\/\/www.who.int\/publications-detail-redirect\/WHO-2019-nCoV-clinical-2021-2. Accessed 20 May 2024"},{"key":"1182_CR84","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1161\/CIRCULATIONAHA.120.050147","volume":"142","author":"Z Belhadjer","year":"2020","unstructured":"Belhadjer Z, Auriau J, M\u00e9ot M, Oualha M, Renolleau S, Houyel L, Bonnet D. Addition of corticosteroids to immunoglobulins is associated with recovery of cardiac function in multi-inflammatory syndrome in children. Circulation. 2020;142:2282\u20134.","journal-title":"Circulation"},{"key":"1182_CR85","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1001\/jama.2021.0694","volume":"325","author":"N Ouldali","year":"2021","unstructured":"Ouldali N, Toubiana J, Antona D, et al. Association of intravenous immunoglobulins plus methylprednisolone vs immunoglobulins alone with course of fever in multisystem inflammatory syndrome in children. JAMA. 2021;325:855\u201364.","journal-title":"JAMA"},{"key":"1182_CR86","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa2102968","volume":"385","author":"AJ McArdle","year":"2021","unstructured":"McArdle AJ, Vito O, Patel H, et al. Treatment of multisystem inflammatory syndrome in children. N Engl J Med. 2021;385:11\u201322.","journal-title":"N Engl J Med"},{"key":"1182_CR87","unstructured":"National Institutes of Health. Hospitalized Children: Therapeutic Management of MIS-C. In: COVID-19 Treatment Guidelines. 2024. https:\/\/www.covid19treatmentguidelines.nih.gov\/management\/clinical-management-of-children\/hospitalized-children-therapeutic-management-of-mis-c\/. Accessed 20 May 2024"},{"key":"1182_CR88","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1001\/jamapediatrics.2022.0292","volume":"176","author":"DS Villacis-Nunez","year":"2022","unstructured":"Villacis-Nunez DS, Jones K, Jabbar A, et al. Short-term outcomes of corticosteroid monotherapy in multisystem inflammatory syndrome in children. JAMA Pediatr. 2022;176:576\u201384.","journal-title":"JAMA Pediatr"},{"key":"1182_CR89","doi-asserted-by":"publisher","first-page":"e184","DOI":"10.1016\/S2665-9913(23)00029-2","volume":"5","author":"S Channon-Wells","year":"2023","unstructured":"Channon-Wells S, Vito O, McArdle AJ, et al. Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study. Lancet Rheumatol. 2023;5:e184\u201399.","journal-title":"Lancet Rheumatol"},{"key":"1182_CR90","doi-asserted-by":"publisher","first-page":"e2022061173","DOI":"10.1542\/peds.2022-061173","volume":"152","author":"N Ouldali","year":"2023","unstructured":"Ouldali N, Son MBF, McArdle AJ, et al. Immunomodulatory therapy for MIS-C. Pediatrics. 2023;152:e2022061173.","journal-title":"Pediatrics"},{"key":"1182_CR91","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S2352-4642(23)00020-2","volume":"7","author":"T Welzel","year":"2023","unstructured":"Welzel T, Atkinson A, Sch\u00f6bi N, et al. Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial. Lancet Child Adolesc Health. 2023;7:238\u201348.","journal-title":"Lancet Child Adolesc Health"},{"key":"1182_CR92","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S2352-4642(23)00316-4","volume":"8","author":"RECOVERY Collaborative Group","year":"2024","unstructured":"RECOVERY Collaborative Group. Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. Lancet Child Adolesc Health. 2024;8:190\u2013200.","journal-title":"Lancet Child Adolesc Health"},{"key":"1182_CR93","doi-asserted-by":"publisher","first-page":"e2241622","DOI":"10.1001\/jamanetworkopen.2022.41622","volume":"5","author":"MBF Son","year":"2022","unstructured":"Son MBF, Berbert L, Young C, et al. Postdischarge glucocorticoid use and clinical outcomes of multisystem inflammatory syndrome in children. JAMA Netw Open. 2022;5:e2241622.","journal-title":"JAMA Netw Open"},{"key":"1182_CR94","doi-asserted-by":"publisher","first-page":"e2021052702","DOI":"10.1542\/peds.2021-052702","volume":"148","author":"LD Cole","year":"2021","unstructured":"Cole LD, Osborne CM, Silveira LJ, et al. IVIG compared with IVIG plus infliximab in multisystem inflammatory syndrome in children. Pediatrics. 2021;148:e2021052702.","journal-title":"Pediatrics"},{"key":"1182_CR95","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/art.42495","volume":"75","author":"JC Chang","year":"2023","unstructured":"Chang JC, Young CC, Muscal E, et al. Variation in early anakinra use and short-term outcomes in multisystem inflammatory syndrome in children. Arthritis Rheumatol. 2023;75:1466\u201376.","journal-title":"Arthritis Rheumatol"},{"key":"1182_CR96","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/BOR.0000000000000889","volume":"34","author":"RQ Cron","year":"2022","unstructured":"Cron RQ. Biologic disease-modifying antirheumatic drugs to treat multisystem inflammatory syndrome in children. Curr Opin Rheumatol. 2022;34:274\u20139.","journal-title":"Curr Opin Rheumatol"},{"key":"1182_CR97","doi-asserted-by":"publisher","first-page":"1144914","DOI":"10.3389\/fped.2023.1144914","volume":"11","author":"E Sedlin","year":"2023","unstructured":"Sedlin E, Lau S, von Bernuth H, Kallinich T, Mayer B. Hemolytic anemia following intravenous immunoglobulins in children with PIMS-TS: Two case reports. Front Pediatr. 2023;11:1144914.","journal-title":"Front Pediatr"},{"key":"1182_CR98","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s00431-021-03935-1","volume":"180","author":"N Abdel-Haq","year":"2021","unstructured":"Abdel-Haq N, Asmar BI, Deza Leon MP, McGrath EJ, Arora HS, Cashen K, Tilford B, Charaf Eddine A, Sethuraman U, Ang JY. SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment. Eur J Pediatr. 2021;180:1581\u201391.","journal-title":"Eur J Pediatr"},{"key":"1182_CR99","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12969-023-00858-z","volume":"21","author":"BLP Dizon","year":"2023","unstructured":"Dizon BLP, Redmond C, Gotschlich EC, et al. Clinical outcomes and safety of anakinra in the treatment of multisystem inflammatory syndrome in children: a single center observational study. Pediatr Rheumatol Online J. 2023;21:76.","journal-title":"Pediatr Rheumatol Online J"},{"key":"1182_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14712598.2022.2006631","volume":"22","author":"MV Mastrolia","year":"2022","unstructured":"Mastrolia MV, Marrani E, Maccora I, Pagnini I, Simonini G. The Role of Anti-IL-1 Treatment in MIS-C Patients. Expert Opin Biol Ther. 2022;22:1\u20135.","journal-title":"Expert Opin Biol Ther"},{"key":"1182_CR101","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/annrheumdis-2020-217960","volume":"79","author":"M Pouletty","year":"2020","unstructured":"Pouletty M, Borocco C, Ouldali N, et al. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort. Ann Rheum Dis. 2020;79:999\u20131006.","journal-title":"Ann Rheum Dis"},{"key":"1182_CR102","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jpeds.2020.06.045","volume":"224","author":"S Kaushik","year":"2020","unstructured":"Kaushik S, Aydin SI, Derespina KR, et al. Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection (MIS-C): A Multi-institutional Study from New York City. J Pediatr. 2020;224:24\u20139.","journal-title":"J Pediatr"},{"key":"1182_CR103","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1016\/j.jtha.2023.05.020","volume":"21","author":"R Kumar","year":"2023","unstructured":"Kumar R, Rivkin MJ, Raffini L. Thrombotic complications in children with Coronavirus disease 2019 and Multisystem Inflammatory Syndrome of Childhood. J Thromb Haemost. 2023;21:2313\u201326.","journal-title":"J Thromb Haemost"},{"key":"1182_CR104","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1182\/blood.2020010218","volume":"138","author":"H Whitworth","year":"2021","unstructured":"Whitworth H, Sartain SE, Kumar R, et al. Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C. Blood. 2021;138:190\u20138.","journal-title":"Blood"},{"key":"1182_CR105","doi-asserted-by":"publisher","first-page":"e29793","DOI":"10.1002\/pbc.29793","volume":"69","author":"S Tehseen","year":"2022","unstructured":"Tehseen S, Williams S, Robinson J, et al. Thrombosis and hemorrhage experienced by hospitalized children with SARS-CoV-2 infection or MIS-C: Results of the PICNIC registry. Pediatr Blood Cancer. 2022;69:e29793.","journal-title":"Pediatr Blood Cancer"},{"key":"1182_CR106","doi-asserted-by":"publisher","first-page":"102358","DOI":"10.1016\/j.eclinm.2023.102358","volume":"67","author":"MC Andre","year":"2024","unstructured":"Andre MC, Sanchez C, Bressieux-Degueldre S, et al. Cardiac assessment and inflammatory markers in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV2 (PIMS-TS) treated with methylprednisolone versus intravenous immunoglobulins: 6-month follow-up outcomes of the randomised controlled Swissped RECOVERY trial. EClinicalMedicine. 2024;67:102358.","journal-title":"EClinicalMedicine"},{"key":"1182_CR107","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1001\/jamapediatrics.2021.2993","volume":"175","author":"P Davies","year":"2021","unstructured":"Davies P, du Pr\u00e9 P, Lillie J, Kanthimathinathan HK. One-Year Outcomes of Critical Care Patients Post-COVID-19 Multisystem Inflammatory Syndrome in Children. JAMA Pediatr. 2021;175:1281\u20133.","journal-title":"JAMA Pediatr"},{"key":"1182_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13052-023-01569-7","volume":"50","author":"A Glazyrina","year":"2024","unstructured":"Glazyrina A, Zholobova E, Iakovleva E, et al. Short-term and medium-term clinical outcomes of multisystem inflammatory syndrome in children: a prospective observational cohort study. Ital J Pediatr. 2024;50:1.","journal-title":"Ital J Pediatr"},{"key":"1182_CR109","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00246-023-03298-4","volume":"45","author":"JT Jose","year":"2024","unstructured":"Jose JT, Tierney ESS. Outpatient Pediatric Cardiology Follow-Up of Patients with Multisystem Inflammatory Syndrome in Children (MIS-C): A Single-Institution, Medium-Term Follow-Up Study. Pediatr Cardiol. 2024;45:401\u20139.","journal-title":"Pediatr Cardiol"},{"key":"1182_CR110","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1017\/S1047951123000793","volume":"33","author":"J Kaltman","year":"2023","unstructured":"Kaltman J, Keesari R, Madani R, Jaggi P, Oster ME. Six-month cardiac outcomes in children with multisystem inflammatory syndrome in children. Cardiol Young. 2023;33:2632\u20138.","journal-title":"Cardiol Young"},{"key":"1182_CR111","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S2352-4642(21)00138-3","volume":"5","author":"J Penner","year":"2021","unstructured":"Penner J, Abdel-Mannan O, Grant K, et al. 6-month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: a retrospective cohort study. Lancet Child Adolesc Health. 2021;5:473\u201382.","journal-title":"Lancet Child Adolesc Health"},{"key":"1182_CR112","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1007\/s00246-022-03052-2","volume":"44","author":"J Yasuhara","year":"2023","unstructured":"Yasuhara J, Masuda K, Watanabe K, Shirasu T, Takagi H, Sumitomo N, Lee S, Kuno T. Longitudinal cardiac outcomes of multisystem inflammatory syndrome in children: a systematic review and meta-analysis. Pediatr Cardiol. 2023;44:892\u2013907.","journal-title":"Pediatr Cardiol"},{"key":"1182_CR113","doi-asserted-by":"publisher","first-page":"1088529","DOI":"10.3389\/fped.2023.1088529","volume":"11","author":"SD You","year":"2023","unstructured":"You SD, Kim JH, You J. Clinical characteristics and short-term outcomes of multisystem inflammatory syndrome in a country with a high prevalence of KD. Front Pediatr. 2023;11:1088529.","journal-title":"Front Pediatr"},{"key":"1182_CR114","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1007\/s00246-023-03375-8","volume":"45","author":"A Anagnostopoulou","year":"2024","unstructured":"Anagnostopoulou A, Dourdouna M-M, Loukopoulou S, Mpourazani E, Poulakis M, Karanasios E, Michos A. Longitudinal Cardiac Evaluation of Children with Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 by Conventional and Speckle-Tracking Echocardiography. Pediatr Cardiol. 2024;45:1110\u20139.","journal-title":"Pediatr Cardiol"},{"key":"1182_CR115","doi-asserted-by":"publisher","first-page":"1253608","DOI":"10.3389\/fped.2023.1253608","volume":"11","author":"R De Wolf","year":"2023","unstructured":"De Wolf R, Zaqout M, Tanaka K, Mui\u00f1o-Mosquera L, van Berlaer G, Vandekerckhove K, Dewals W, De Wolf D. Evaluation of late cardiac effects after multisystem inflammatory syndrome in children. Front Pediatr. 2023;11:1253608.","journal-title":"Front Pediatr"},{"key":"1182_CR116","first-page":"113516","volume":"260","author":"H Kami\u0144ska","year":"2023","unstructured":"Kami\u0144ska H, Ro\u017cnowska-W\u00f3jtowicz A, Cacko A, Okarska-Napiera\u0142a M, Kuchar E, Werner B. Three-dimensional echocardiography and global longitudinal strain in follow-up after multisystem inflammatory syndrome in children: six-month, single-center. Prospective Study J Pediatr. 2023;260:113516.","journal-title":"Prospective Study J Pediatr"},{"key":"1182_CR117","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.cjco.2021.02.012","volume":"3","author":"R Kobayashi","year":"2021","unstructured":"Kobayashi R, Dionne A, Ferraro A, et al. Detailed Assessment of Left Ventricular Function in Multisystem Inflammatory Syndrome in Children, Using Strain Analysis. CJC Open. 2021;3:880\u20137.","journal-title":"CJC Open"},{"key":"1182_CR118","doi-asserted-by":"publisher","unstructured":"Sabri MR, Ahmadi A, Saviz M, Ghaderian M, Dehghan B, Mahdavi C, Ramezani Nezhad D, Rahimi H, Mostafavi N, Pourmoghaddas Z. Cardiac function in pediatric patients with MIS-C using speckle tracking and conventional echocardiography: a longitudinal, single-center study. Pediatr Cardiol. 2024. https:\/\/doi.org\/10.1007\/s00246-024-03432-w","DOI":"10.1007\/s00246-024-03432-w"},{"key":"1182_CR119","first-page":"308","volume":"11","author":"J You","year":"2024","unstructured":"You J. Echocardiographic Strain Evaluation Shows Persistent Echocardiographic Changes at 1 Year after Diagnosis of Multisystem Inflammatory Syndrome in Children. Children (Basel). 2024;11:308.","journal-title":"Children (Basel)"},{"key":"1182_CR120","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1001\/jamapediatrics.2023.6022","volume":"178","author":"J Boever","year":"2024","unstructured":"Boever J, Nussbaum C, Arnold L, Haas NA, Dold SK, Oberhoffer FS, Jakob A. Long-Term Microvascular Changes in Multisystem Inflammatory Syndrome in Children. JAMA Pediatr. 2024;178:304\u20136.","journal-title":"JAMA Pediatr"},{"key":"1182_CR121","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s00246-023-03394-5","volume":"45","author":"M Beaver","year":"2024","unstructured":"Beaver M, Jepson B, Binka E, et al. Baseline Echocardiography and Laboratory Findings in MIS-C and Associations with Clinical Illness Severity. Pediatr Cardiol. 2024;45:560\u20139.","journal-title":"Pediatr Cardiol"},{"key":"1182_CR122","doi-asserted-by":"publisher","first-page":"E513","DOI":"10.1503\/cmaj.210873","volume":"194","author":"J Merckx","year":"2022","unstructured":"Merckx J, Cooke S, El Tal T, et al. Predictors of severe illness in children with multisystem inflammatory syndrome after SARS-CoV-2 infection: a multicentre cohort study. CMAJ. 2022;194:E513\u201323.","journal-title":"CMAJ"},{"key":"1182_CR123","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/PCC.0000000000003212","volume":"24","author":"MM Bembea","year":"2023","unstructured":"Bembea MM, Loftis LL, Thiagarajan RR, et al. Extracorporeal membrane oxygenation characteristics and outcomes in children and adolescents with COVID-19 or multisystem inflammatory syndrome admitted to U.S. ICUs Pediatr Crit Care Med. 2023;24:356\u201371.","journal-title":"ICUs Pediatr Crit Care Med"},{"key":"1182_CR124","doi-asserted-by":"publisher","first-page":"981711","DOI":"10.3389\/fped.2022.981711","volume":"10","author":"P Buda","year":"2022","unstructured":"Buda P, Strauss E, Januszkiewicz-Lewandowska D, Czerwinska E, Ludwikowska K, Szenborn L, Gowin E, Okarska-Napiera\u0142a M, Kuchar E, Ksiazyk J. Clinical characteristics of children with MIS-C fulfilling classification criteria for macrophage activation syndrome. Front Pediatr. 2022;10:981711.","journal-title":"Front Pediatr"},{"key":"1182_CR125","doi-asserted-by":"publisher","first-page":"e2414122","DOI":"10.1001\/jamanetworkopen.2024.14122","volume":"7","author":"C Francoeur","year":"2024","unstructured":"Francoeur C, Alcamo AM, Robertson CL, et al. Severe pediatric neurological manifestations with SARS-CoV-2 or MIS-C hospitalization and new morbidity. JAMA Netw Open. 2024;7:e2414122.","journal-title":"JAMA Netw Open"},{"key":"1182_CR126","doi-asserted-by":"publisher","first-page":"1260372","DOI":"10.3389\/fped.2023.1260372","volume":"11","author":"AB Maddux","year":"2023","unstructured":"Maddux AB, Young CC, Kucukak S, et al. Risk factors for health impairments in children after hospitalization for acute COVID-19 or MIS-C. Front Pediatr. 2023;11:1260372.","journal-title":"Front Pediatr"},{"key":"1182_CR127","doi-asserted-by":"publisher","first-page":"100760","DOI":"10.1016\/j.bbih.2024.100760","volume":"38","author":"T Pan","year":"2024","unstructured":"Pan T, Gallo ME, Donald KA, Webb K, Bath KG. Elevated risk for psychiatric outcomes in pediatric patients with Multisystem Inflammatory Syndrome (MIS-C): A review of neuroinflammatory and psychosocial stressors. Brain Behav Immun Health. 2024;38:100760.","journal-title":"Brain Behav Immun Health"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-025-01182-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-025-01182-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-025-01182-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:03:49Z","timestamp":1770750229000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-025-01182-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":127,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1182"],"URL":"https:\/\/doi.org\/10.1007\/s11926-025-01182-z","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"assertion":[{"value":"15 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"16"}}